abstract |
The present invention provides such antibodies and compositions for the treatment of human cancer, eg, breast cancer, ovarian cancer, gastric cancer and other cancers that overexpress HER2. A novel therapeutic antibody directed against HER2 (ErbB2), a recombinant polyclonal anti-HER2 antibody composition comprising at least two said recombinant anti-HER2 antibodies, as well as for the treatment of cancer Of antibodies and antibody compositions are provided. [Selection figure] None |